Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.32 USD | -1.49% | +3.94% | +25.71% |
Jul. 16 | Aclaris Therapeutics Sells Olumiant Royalties, Milestone Payments From Eli Lilly | MT |
Jul. 05 | Aclaris Therapeutics Insider Bought Shares Worth $405,894, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.71% | 94.07M | |
+24.74% | 47.54B | |
-0.47% | 41.96B | |
+45.83% | 41.55B | |
+25.40% | 30.36B | |
+17.96% | 27.61B | |
-4.47% | 28.7B | |
+50.73% | 14.7B | |
+42.56% | 13.51B | |
+1.46% | 12.34B |
- Stock Market
- Equities
- ACRS Stock
- News Aclaris Therapeutics, Inc.
- HC Wainwright Cuts Price Target on Aclaris Therapeutics to $9 From $43, Maintains Buy Rating